Evidence map›Paper›PMID 40121962›Full record

ArticleThe journal of nutrition, health & aging2025

Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer's disease: A cross-sectional study.

Marie Collin, Justine Bonnet-Chateau, Victor Gilles, Sophie Dautricourt, Thomas Gilbert, Zaza Makaroff, Marie-Hélène Coste, Virginie Dauphinot, Antoine Garnier-Crussard

Abstract readComparative Study
In one paragraph

Article in The journal of nutrition, health & aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Intrinsic capacity in Lewy body dementia: a review.The Journal of frailty & aging · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marie CollinClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France.
Justine Bonnet-ChateauClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France.
Victor GillesClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France.
Sophie DautricourtClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France; Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Neuropresage Team, Cyceron, 14000 Caen, France.
Thomas GilbertResearch on Healthcare Professionals and Performance RESHAPE, Inserm U1290, Université Claude Bernard Lyon 1, 69008 Lyon, France; Geriatric Medicine Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, CEDEX, 69495 Pierre-Bénite, France.
Zaza MakaroffClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France.
Marie-Hélène CosteClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France.
Virginie DauphinotClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France.
Antoine Garnier-CrussardClinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Lyon Institute for Aging, Charpennes Hospital, Clinical Research Center Aging-Brain-Frailty, Hospices Civils de Lyon, Villeurbanne, France; Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Neuropresage Team, Cyceron, 14000 Caen, France; University Claude Bernard Lyon 1, Villeurbanne, France. Electronic address: antoine.garnier-crussard@chu-lyon.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIntrinsic capacity (IC), the composite of all the physical and mental capacities of an individual, has never been studied in patients with dementia with Lewy bodies (DLB). As IC decline is associated with the risk of frailty, functional decline and disability and is potentially reversible after targeted interventions, a monitoring and specific management of IC decline in patients with DLB could promote healthy aging in this population. The aim of this cross-sectional study was to describe the frequency of IC decline in DLB and to compare it with AD.

designA single-center cross-sectional study.

settingThis study was carried out in a memory clinic between 2015 and 2023 based on the MEMORA cohort.

participantsPatients with a diagnosis of AD or probable DLB and a comprehensive geriatric assessment. MEASUREMENTS: IC was assessed according to the WHO model in 4 domains: vitality assessed by the Mini Nutritional Assessment (MNA), locomotion assessed by the Short Physical Performance Battery (SPPB), psychology assessed by the Geriatric Depression Scale 4-items (GDS-4 items), and hearing assessed by the Hearing, Vision, Equilibrium and Cognition (HVEC) scale.

resultsA total of 798 patients (154 with probable DLB and 644 with AD) were included, and the mean age was 81.4 years (SD 6.33). Compared with AD patients, DLB patients had significantly more impaired IC in all domains, with greater risks of impaired vitality (odds ratio (OR) 2.43, 95% confidence interval (CI) 1.60-3.72), locomotion (OR 3.50, 95% CI 2.15-5.90), psychology (OR 2.60, 95% CI 1.73-3.92) and hearing (OR 2.30, 95% CI 1.53-3.49), according to the adjusted models. Similarly, when IC domains were considered linear variables, IC across all domains was significantly lower in the DLB group than in the AD group.

conclusionThis study revealed that DLB patients presented a greater decrease in IC than did AD patients across all domains. In memory clinics, DLB patients could be offered systematic and early IC monitoring and personalized interventions.

Indexed as

Alzheimer DiseaseLewy Body DiseaseAgedAged, 80 and overCognitionCross-Sectional StudiesFemaleGeriatric AssessmentHumansMaleAlzheimer’s diseaseDementia with Lewy bodiesIntrinsic capacity

Identifiers

PMID40121962
PMCPMC12172994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.